https://www.selleckchem.com/products/bapta-am.html
f exertion to match combat conditions. A prospective 2002-2014 study stratified 160 patients by resection extent and histological grade, reporting results in 2016. We reanalyzed the series after a median 119 months, adding retrospectively patients' molecular features. Follow-up of all patients was updated. DNA copy-number analysis and gene-fusion detection could be completed for 94/160 patients, methylation classification for 68. PFS and OS at five/ten years were 66/58%, and 80/73%. Ten patients had late relapses (range 66-126 months),
Like
Comment
Share
